文献速递妇科

曼彻斯特手术与骶棘韧带子宫悬吊术治疗子宫脱垂后性功能比较:一项随机临床试验的计划分析

Sexual function after the manchester procedure versus sacrospinous hysteropexy in women treated for uterine prolapse: a planned analysis of a randomized clinical trial.
PubMed 文献 · Am J Obstet Gynecol · 2025-12-17

这项多中心随机临床试验的预设分析比较曼彻斯特手术与骶棘韧带子宫悬吊术治疗轻度至中度子宫脱垂后24个月的性功能。393名女性完成问卷,性活跃患者中两组性功能评分均改善,组间平均差异0.09分(95%CI 0.01-0.17),完全落在预设等效界值±0.31内,提示两种手术在性功能改善方面等效;新发性交痛在性活跃患者中曼彻斯特手术组5%、骶棘韧带子宫悬吊术组13%,差异未达统计学显著。

要点

  • 性活跃患者中,曼彻斯特手术组评分改善0.27分(95%CI 0.19-0.34),骶棘韧带子宫悬吊术组改善0.20分(95%CI 0.11-0.29)。
  • 组间平均差异0.09分(95%CI 0.01-0.17)完全在预设等效界值±0.31内,提示性功能改善等效。
  • 性活跃患者新发性交痛曼彻斯特手术组5% vs 骶棘韧带子宫悬吊术组13%,差异未达统计学显著。

核心结论

  • 曼彻斯特手术与骶棘韧带子宫悬吊术导致相似的性功能改善,两组问卷评分和新发性交痛率无相关差异。
  • 曼彻斯特手术此前已显示在盆腔器官脱垂相关结局方面更有效,本研究中两种手术对性功能有相似的积极影响。

研究设计与样本

  • 多中心随机临床试验的资料分析,评估曼彻斯特手术 vs 骶棘韧带子宫悬吊术治疗原发性轻度至中度子宫脱垂。
  • 主要结局为盆腔器官脱垂/尿失禁性问卷-IUGA修订版(PISQ-IR)评分从基线至24个月随访的变化。
  • 采用等效设计,预设界值为±0.31分,对应PISQ-IR总分的微效临床重要差异。
  • 性活跃和性不活跃女性完成不同问卷,因此活动状态交叉的患者单独分析。
  • 共393名女性(曼彻斯特手术=197,骶棘韧带子宫悬吊术=196)完成基线和24个月随访的PISQ-IR问卷。

主要发现

  • 性活跃患者(曼彻斯特手术=101,骶棘韧带子宫悬吊术=99)中,曼彻斯特手术组PISQ-IR评分平均改善0.27分(95%CI 0.19-0.34),骶棘韧带子宫悬吊术组改善0.20分(95%CI 0.11-0.29)。
  • 曼彻斯特手术与骶棘韧带子宫悬吊术的组间平均差异为0.09分(95%CI 0.01-0.17),完全落在预设等效界值±0.31内,提示性功能改善等效;该差异有利于曼彻斯特手术,但低于微效临床重要差异。
  • 性活跃患者中新发性交痛两组无显著差异(曼彻斯特手术5% vs 骶棘韧带子宫悬吊术13%;95%CI 0.1%至16.5%)。
  • 纳入术后变为性不活跃的女性后,新发性交痛在曼彻斯特手术组为6%(n=7),骶棘韧带子宫悬吊术组为11%(n=12)(95%CI 1.5%至13.9%)。
  • 性不活跃患者(曼彻斯特手术=59,骶棘韧带子宫悬吊术=64)中,条件影响评分在曼彻斯特手术组下降-0.25(95%CI -0.43至0.08),骶棘韧带子宫悬吊术组下降-0.21(95%CI -0.41至0.00),表明疾病对性活动状态的影响减小;两种手术间条件影响评分无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While sexual function typically improves after pelvic organ prolapse surgery, there are still general concerns about the risk of developing de novo dyspareunia. A recent randomized clinical trial showed inferiority of the sacrospinous hysteropexy compared to the Manchester procedure regarding surgical success at 2-year follow-up. In this study, we present the data regarding postoperative sexual function from this randomized clinical trial. OBJECTIVE: This study compares the effect of sacrospinous hysteropexy and the Manchester procedure on sexual function and (de novo) dyspareunia at 24-month follow-up and tests whether both procedures are equivalent within predefined margins. STUDY DESIGN: Analysis of the data on sexual function from a multicenter randomized clinical trial evaluating Manchester procedure vs sacrospinous hysteropexy in the treatment of primary mild to moderate uterine prolapse. The primary outcome was the change in score on the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-IUGA-Revised between baseline and 24-month follow-up. An equivalence design was applied with a predefined margin of ±0.31 points, corresponding to the minimally clinically important difference for the total Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-IUGA-Revised score. Sexually active and inactive women completed different questionnaires, and therefore patients who crossed over to the other activity status were analyzed separately. Secondary outcomes were the incidence of dyspareunia and de novo dyspareunia. RESULTS: A total of 393 women (Manchester procedure=197, sacrospinous hysteropexy=196) completed the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-IUGA-Revised questionnaire at baseline and after 24 months of follow-up. In sexually active patients (Manchester procedure=101, sacrospinous hysteropexy=99), the mean Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-IUGA-Revised score improved within the groups: 0.27 points (95% confidence interval, 0.19-0.34) after Manchester procedure and 0.20 points (95% confidence interval, 0.11-0.29) after sacrospinous hysteropexy. The mean difference between Manchester procedure and sacrospinous hysteropexy was 0.09 (95% confidence interval, 0.01-0.17), which lies entirely within the predefined equivalence margin of ±0.31, indicating equivalence regarding improvement in sexual function. This difference favored Manchester procedure, but was below the minimally clinically important difference. De novo dyspareunia in sexually active patients did not differ significantly between groups (Manchester procedure 5%, sacrospinous hysteropexy 13%; 95% confidence interval, 0.1% to 16.5%). After incorporating outcomes from women who became nonsexually active postsurgery, de novo dyspareunia was 6% (n=7) in the Manchester procedure group and 11% (n=12) in the sacrospinous hysteropexy group (95% confidence interval, 1.5% to 13.9%). In nonsexually active patients (Manchester procedure=59, sacrospinous hysteropexy=64), the condition-impact score decreased after both Manchester procedure (-0.25 [95% confidence interval, -0.43 to 0.08]) and sacrospinous hysteropexy (-0.21 [95% confidence interval, -0.41 to 0.00]), indicating a lesser impact of the condition on sexual activity status. No differences were observed between the procedures in condition-impact score. Twenty-four percent of patients (Manchester procedure, n=20; sacrospinous hysteropexy, n=19) who had not been sexually active preoperatively transitioned to a sexually active status at 24 months postoperatively. CONCLUSION: Manchester procedure and sacrospinous hysteropexy lead to a similar improvement in sexual function, and there are no relevant differences in questionnaire scores and de novo dyspareunia rates between groups. Manchester procedure has previously shown to be more effective with regards to the pelvic organ prolapse-related outcomes, and in the present study, a similar positive impact on sexual function was found.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Stoter LM, Peters K, Enklaar RA, et al. Sexual function after the manchester procedure versus sacrospinous hysteropexy in women treated for uterine prolapse: a planned analysis of a randomized clinical trial. Am J Obstet Gynecol. 2025. PMID: 41419154. doi:10.1016/j.ajog.2025.12.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。